Sermorelin

What is Sermorelin?

Sermorelin is a synthetic peptide made of the first 29 amino acids of human growth-hormone-releasing hormone (GHRH) — the fragment, known as GRF(1-29), that carries the full biological activity of the natural hormone. Rather than supplying growth hormone directly, it signals your own pituitary gland to make and release more of its own.

This is an important distinction. Sermorelin has a notable regulatory history: it was FDA-approved and marketed as Geref for the diagnosis and treatment of growth-hormone deficiency, but the branded product was discontinued (a commercial decision, not a safety withdrawal). Today it is available in the United States only as a pharmacy-compounded preparation prescribed under physician supervision, not as an off-the-shelf FDA-approved drug.

How Sermorelin works

Sermorelin binds the GHRH receptor on the somatotroph cells of the anterior pituitary, prompting them to synthesize and secrete growth hormone in a natural, pulsatile pattern. Because the pituitary remains in control, output is still governed by the body's own feedback loops — including somatostatin, the hormone that brakes GH release — which is thought to reduce the risk of the sustained, supraphysiologic levels seen with injected growth hormone itself.

The released growth hormone in turn stimulates the liver to produce insulin-like growth factor 1 (IGF-1), the downstream mediator of many of GH's effects on tissue repair, lean-mass maintenance, and metabolism. Because sermorelin works upstream at the pituitary, it depends on a functioning gland to produce an effect.

What Sermorelin is used for

What the evidence shows

Sermorelin has a longer clinical track record than most peptides in this category, precisely because it was developed and studied as an approved drug. It was validated as a diagnostic agent for growth-hormone deficiency and studied in the treatment of GH-deficient children, where it increased GH and IGF-1 levels and supported growth [1][2].

In adults, the evidence for anti-aging and body-composition goals is thinner and more mixed. GHRH analogs can raise GH and IGF-1 in older adults, and some studies report modest effects on body composition [3] — but large, long-term trials establishing durable functional benefits or safety for these off-label uses are limited.

We present this honestly. Sermorelin's mechanism and diagnostic-era data are well characterized, but its use for healthy aging and recovery rests more on physiologic rationale and short-term hormonal endpoints than on definitive outcome trials. That distinction matters when you are deciding whether it fits your goals.

Dosing & administration context

Sermorelin is administered by subcutaneous injection, most often at night to align with the body's natural nocturnal GH pulse and to avoid the competing effect of food-related insulin and blood glucose. Protocols in clinical use are individualized and typically run over months, with periodic reassessment.

The specific dose, timing, and duration are set by the prescribing physician based on your goals, labs (including IGF-1), and response — which is why we frame this as clinical context, not a self-dosing guide. Sermorelin obtained without a prescription (research-only vials, gray-market powders) carries no guarantee of identity, purity, or sterility, and the peptide is also sensitive to handling and storage.

Sermorelin was formerly FDA-approved (Geref, since discontinued) and is now available only as a pharmacy-compounded preparation. Content on this page is clinical context for physician-supervised use — not a dosing guide or a substitute for medical advice.

Safety & side effects

Sermorelin's safety profile is relatively well characterized from its history as an approved product. Because it stimulates the pituitary rather than flooding the body with exogenous growth hormone, and because natural feedback mechanisms remain intact, it is generally considered to carry a lower risk of GH excess than injected growth hormone.

That said, it still raises GH and IGF-1, so we screen carefully before prescribing and monitor throughout a course — including IGF-1 levels. The most important safety principle is source control: a pharmacy-compounded product from a licensed 503A/503B pharmacy is a fundamentally different risk profile than a research vial of unknown origin.

How Strong Health prescribes Sermorelin

At Strong Health, sermorelin is prescribed only after a physician evaluation, a review of your goals and history, and baseline labs including IGF-1. It is dispensed exclusively through licensed 503A or 503B compounding pharmacies under physician orders; we do not sell or recommend research-only product.

We treat sermorelin as one component of a plan built on training, sleep, and nutrition, not a standalone fix. It is frequently combined with a GH-releasing peptide such as ipamorelin for a complementary effect. Your physician sets the protocol, rechecks IGF-1 and your response at scheduled intervals, and adjusts or stops treatment based on how you actually respond.

Available in person at our Miami (Brickell) clinic and via telehealth across our service areas.

Frequently asked questions